DEUTSCHE BANK AG\ - HERON THERAPEUTICS INC ownership

HERON THERAPEUTICS INC's ticker is HRTX and the CUSIP is 427746102. A total of 200 filers reported holding HERON THERAPEUTICS INC in Q3 2021. The put-call ratio across all filers is 0.54 and the average weighting 0.2%.

Quarter-by-quarter ownership
DEUTSCHE BANK AG\ ownership history of HERON THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$46,918
-11.2%
45,5510.0%0.00%
Q2 2023$52,839
-47.9%
45,551
-32.2%
0.00%
Q1 2023$101,380
-20.0%
67,139
+32.4%
0.00%
Q4 2022$126,780
-40.2%
50,712
+1.4%
0.00%
Q3 2022$212,000
+37.7%
50,023
-9.3%
0.00%
Q2 2022$154,000
-86.1%
55,167
-71.6%
0.00%
-100.0%
Q1 2022$1,110,000
-68.7%
194,095
-50.1%
0.00%
-50.0%
Q4 2021$3,548,000
-37.3%
388,630
-26.6%
0.00%
-33.3%
Q3 2021$5,659,000
-30.0%
529,340
+1.7%
0.00%
-25.0%
Q2 2021$8,081,000
+18.9%
520,685
+24.2%
0.00%0.0%
Q1 2021$6,794,000
-53.6%
419,123
-39.4%
0.00%
-55.6%
Q4 2020$14,632,000
+62.6%
691,328
+13.8%
0.01%
+50.0%
Q3 2020$9,001,000
+3.2%
607,301
+2.4%
0.01%
-14.3%
Q2 2020$8,726,000
+76.6%
593,241
+40.9%
0.01%
+75.0%
Q1 2020$4,942,000
-59.8%
420,951
-19.6%
0.00%
-50.0%
Q4 2019$12,295,000
+37.8%
523,312
+8.5%
0.01%
+33.3%
Q3 2019$8,923,000
-9.0%
482,454
-8.6%
0.01%0.0%
Q2 2019$9,806,000
+11.9%
527,641
+47.1%
0.01%
+20.0%
Q1 2019$8,763,000
+315.3%
358,670
+340.6%
0.01%
+400.0%
Q4 2018$2,110,000
-93.8%
81,407
-92.4%
0.00%
-90.0%
Q3 2018$33,993,000
-43.8%
1,074,071
-31.0%
0.01%
-41.2%
Q2 2018$60,437,000
+194.5%
1,555,674
+109.2%
0.02%
+70.0%
Q1 2018$20,524,000
+157.3%
743,717
+68.7%
0.01%
+100.0%
Q4 2017$7,976,000
+23.0%
440,862
+9.8%
0.01%
+25.0%
Q3 2017$6,482,000
-26.5%
401,526
-36.9%
0.00%
-33.3%
Q2 2017$8,817,000
-15.7%
636,774
-8.7%
0.01%
-25.0%
Q1 2017$10,459,000
+212.7%
697,417
+172.9%
0.01%
+166.7%
Q4 2016$3,345,000
+98.2%
255,534
+160.5%
0.00%
+200.0%
Q3 2016$1,688,000
-34.9%
98,089
-31.8%
0.00%
-50.0%
Q2 2016$2,594,000
+107.5%
143,830
+118.1%
0.00%
+100.0%
Q1 2016$1,250,000
-32.7%
65,939
-5.3%
0.00%0.0%
Q4 2015$1,858,000
-26.3%
69,648
-32.6%
0.00%
-50.0%
Q3 2015$2,520,000
-51.0%
103,355
-37.4%
0.00%
-33.3%
Q2 2015$5,146,000
+196.8%
165,203
+38.5%
0.00%
+200.0%
Q1 2015$1,734,000
+54.4%
119,256
+6.7%
0.00%0.0%
Q4 2014$1,123,000
+54.7%
111,784
+27.9%
0.00%
Q3 2014$726,000
-28.5%
87,426
+6.0%
0.00%
-100.0%
Q2 2014$1,015,000
+2206.8%
82,476
+2466.9%
0.00%
Q1 2014$44,0003,2130.00%
Other shareholders
HERON THERAPEUTICS INC shareholders Q3 2021
NameSharesValueWeighting ↓
TANG CAPITAL MANAGEMENT LLC 8,648,252$238,692,00035.08%
Broadfin Capital, LLC 1,581,416$43,647,0006.80%
Tavio Capital LLC 351,729$9,708,0004.58%
Mesirow Financial Investment Management, Inc. 33,389$922,0003.88%
Rubric Capital Management LP 1,510,008$41,676,0003.88%
KINGDON CAPITAL MANAGEMENT, L.L.C. 1,666,229$45,988,0003.63%
First Light Asset Management, LLC 473,275$13,062,0002.87%
Asymmetry Capital Management, L.P. 77,346$2,135,0002.67%
Copernicus Capital Management, LLC 108,000$2,981,0002.38%
BRIDGER MANAGEMENT, LLC 1,277,560$35,261,0002.14%
View complete list of HERON THERAPEUTICS INC shareholders